UCHL1 and amyotrophic lateral sclerosis: The increased CSF levels of UCHL1 in patients with ALS may be a marker for increased cellular degeneration and loss of UCHL1 to the extracellular environment similar to models proposed for increased Neurofilament light (NfL) in ALS CSF (Bridel et al. 2019).